Literature DB >> 15699124

CCR8 is expressed by antigen-elicited, IL-10-producing CD4+CD25+ T cells, which regulate Th2-mediated granuloma formation in mice.

Christine M Freeman1, Bo-Chin Chiu, Valerie R Stolberg, Jerry Hu, Kyriaki Zeibecoglou, Nicholas W Lukacs, Sergio A Lira, Steven L Kunkel, Stephen W Chensue.   

Abstract

CCR8 was initially described as a Th2 cell-restricted receptor, but this has not been fully tested in vivo. The present study used ex vivo and in vivo approaches to examine the distribution and functional significance of CCR8 among CD4+ T cells. Populations of cytokine-secreting CD4+ T cells were generated in primed mice with Th1 or Th2 cell-mediated pulmonary granulomas, respectively elicited by i.v. challenge with either Mycobacteria bovis purified protein derivative- or Schistosoma mansoni egg Ag (SEA)-coated beads. Cytokine-producing CD4+ T cells were isolated from Ag-stimulated draining lymph node cultures by positive selection. Quantitative analysis of cytokine mRNA indicated enriched populations of IFN-gamma-, IL-4-, and IL-10-producing cells. Analysis of chemokine receptor mRNA indicated that IL-10+ cells selectively expressed CCR8 in the SEA bead-elicited type 2 response. The IL-10+CCR8+ populations were CD25+ and CD44+ but lacked enhanced Foxp3 expression. Adoptive transfer to naive recipients indicated that IL-10+ T cells alone could not transfer type 2 inflammation. Analysis of SEA bead-challenged CCR8-/- mice indicated significantly impaired IL-10 production as well as reductions in granuloma eosinophils. Adoptive transfer of CD4+CCR8+/+ T cells corrected cytokine and inflammation defects, but the granuloma eosinophil recruitment defect persisted when donor cells were depleted of IL-10+ cells. Accordingly, local IL-10 production correlated with CCR8 ligand (CCL1) expression and the appearance of CCR8+ cells in granulomatous lungs. Thus, IL-10-producing, CCR8+CD4+CD25+CD44+ T cells are generated during SEA challenge, which augment the Th2-mediated eosinophil-rich response to the parasite Ags.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15699124      PMCID: PMC1599789          DOI: 10.4049/jimmunol.174.4.1962

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

1.  Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology.

Authors:  Sarah C Higgins; Ed C Lavelle; Chantelle McCann; Brian Keogh; Edel McNeela; Patricia Byrne; Brian O'Gorman; Andrew Jarnicki; Peter McGuirk; Kingston H G Mills
Journal:  J Immunol       Date:  2003-09-15       Impact factor: 5.422

Review 2.  Development and function of CD25+CD4+ regulatory T cells.

Authors:  Zoltán Fehérvari; Shimon Sakaguchi
Journal:  Curr Opin Immunol       Date:  2004-04       Impact factor: 7.486

Review 3.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

Authors:  T R Mosmann; R L Coffman
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

Review 4.  The role of IL-10 in crossregulation of TH1 and TH2 responses.

Authors:  T R Mosmann; K W Moore
Journal:  Immunol Today       Date:  1991-03

5.  Cytokine function during mycobacterial and schistosomal antigen-induced pulmonary granuloma formation. Local and regional participation of IFN-gamma, IL-10, and TNF.

Authors:  S W Chensue; K S Warmington; J H Ruth; P Lincoln; S L Kunkel
Journal:  J Immunol       Date:  1995-06-01       Impact factor: 5.422

6.  Th2 cells are less susceptible than Th1 cells to the suppressive activity of CD25+ regulatory thymocytes because of their responsiveness to different cytokines.

Authors:  Lorenzo Cosmi; Francesco Liotta; Roberta Angeli; Benedetta Mazzinghi; Veronica Santarlasci; Roberto Manetti; Laura Lasagni; Vittorio Vanini; Paola Romagnani; Enrico Maggi; Francesco Annunziato; Sergio Romagnani
Journal:  Blood       Date:  2003-12-24       Impact factor: 22.113

7.  CD25+CD4+ cells contribute to Th2 polarization during helminth infection by suppressing Th1 response development.

Authors:  Amy S McKee; Edward J Pearce
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

8.  The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells.

Authors:  Matthias Hesse; Ciriaco A Piccirillo; Yasmine Belkaid; Jeannette Prufer; Margaret Mentink-Kane; Mary Leusink; Allen W Cheever; Ethan M Shevach; Thomas A Wynn
Journal:  J Immunol       Date:  2004-03-01       Impact factor: 5.422

Review 9.  Regulatory T cells control the development of allergic disease and asthma.

Authors:  Dale T Umetsu; Omid Akbari; Rosemarie H Dekruyff
Journal:  J Allergy Clin Immunol       Date:  2003-09       Impact factor: 10.793

10.  Egg deposition is the major stimulus for the production of Th2 cytokines in murine schistosomiasis mansoni.

Authors:  J M Grzych; E Pearce; A Cheever; Z A Caulada; P Caspar; S Heiny; F Lewis; A Sher
Journal:  J Immunol       Date:  1991-02-15       Impact factor: 5.422

View more
  22 in total

1.  Distinct chemokine and cytokine gene expression pattern of murine dendritic cells and macrophages in response to Mycobacterium tuberculosis infection.

Authors:  Sihyug Jang; Aleksandra Uzelac; Padmini Salgame
Journal:  J Leukoc Biol       Date:  2008-08-14       Impact factor: 4.962

2.  CCR8+FOXp3+ Treg cells as master drivers of immune regulation.

Authors:  Yiftah Barsheshet; Gizi Wildbaum; Eran Levy; Alon Vitenshtein; Chika Akinseye; Jeremy Griggs; Sergio A Lira; Nathan Karin
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-22       Impact factor: 11.205

3.  Characterization of the Histoplasma capsulatum-induced granuloma.

Authors:  Erika Heninger; Laura H Hogan; Jozsef Karman; Sinarack Macvilay; Bjork Hill; Jon P Woods; Matyas Sandor
Journal:  J Immunol       Date:  2006-09-01       Impact factor: 5.422

4.  CCR4 participation in Th type 1 (mycobacterial) and Th type 2 (schistosomal) anamnestic pulmonary granulomatous responses.

Authors:  Christine M Freeman; Valerie R Stolberg; Bo-Chin Chiu; Nicholas W Lukacs; Steven L Kunkel; Stephen W Chensue
Journal:  J Immunol       Date:  2006-09-15       Impact factor: 5.422

Review 5.  Immunopathology of schistosomiasis.

Authors:  Mark S Wilson; Margaret M Mentink-Kane; John T Pesce; Thirumalai R Ramalingam; Robert Thompson; Thomas A Wynn
Journal:  Immunol Cell Biol       Date:  2006-12-12       Impact factor: 5.126

6.  A key role for CC chemokine receptor 1 in T-cell-mediated respiratory inflammation.

Authors:  Matthew A Schaller; Lara E Kallal; Nicholas W Lukacs
Journal:  Am J Pathol       Date:  2008-01-17       Impact factor: 4.307

7.  Schistosoma mansoni antigens modulate experimental allergic asthma in a murine model: a major role for CD4+ CD25+ Foxp3+ T cells independent of interleukin-10.

Authors:  Lucila G G Pacífico; Fábio A V Marinho; Cristina T Fonseca; Michele M Barsante; Vanessa Pinho; Policarpo A Sales-Junior; Luciana S Cardoso; Maria Ilma Araújo; Edgar M Carvalho; Geovanni D Cassali; Mauro M Teixeira; Sergio C Oliveira
Journal:  Infect Immun       Date:  2008-09-29       Impact factor: 3.441

Review 8.  Protective immune mechanisms in helminth infection.

Authors:  Robert M Anthony; Laura I Rutitzky; Joseph F Urban; Miguel J Stadecker; William C Gause
Journal:  Nat Rev Immunol       Date:  2007-12       Impact factor: 53.106

9.  Mononuclear phagocyte-derived interleukin-10 suppresses the innate pulmonary granuloma cytokine response in aged mice.

Authors:  Bo-Chin Chiu; Valerie R Stolberg; Christine M Freeman; Stephen W Chensue
Journal:  Am J Pathol       Date:  2007-07-13       Impact factor: 4.307

10.  CCR8 marks highly suppressive Treg cells within tumours but is dispensable for their accumulation and suppressive function.

Authors:  Sarah K Whiteside; Francis M Grant; David S Gyori; Alberto G Conti; Charlotte J Imianowski; Paula Kuo; Rabab Nasrallah; Firas Sadiyah; Sergio A Lira; Frank Tacke; Robert L Eil; Oliver T Burton; James Dooley; Adrian Liston; Klaus Okkenhaug; Jie Yang; Rahul Roychoudhuri
Journal:  Immunology       Date:  2021-05-09       Impact factor: 7.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.